A detailed history of Charles Schwab Investment Management Inc transactions in Arvinas, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 530,669 shares of ARVN stock, worth $9.94 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
530,669
Previous 544,503 2.54%
Holding current value
$9.94 Million
Previous $14.5 Million 9.82%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$23.66 - $32.73 $327,312 - $452,786
-13,834 Reduced 2.54%
530,669 $13.1 Million
Q2 2024

Aug 12, 2024

BUY
$24.46 - $40.4 $402,318 - $664,499
16,448 Added 3.11%
544,503 $14.5 Million
Q1 2024

May 08, 2024

BUY
$36.38 - $52.31 $2.13 Million - $3.06 Million
58,581 Added 12.48%
528,055 $21.8 Million
Q4 2023

Feb 06, 2024

BUY
$14.19 - $42.33 $560,277 - $1.67 Million
39,484 Added 9.18%
469,474 $19.3 Million
Q3 2023

Nov 08, 2023

BUY
$19.64 - $28.21 $1.3 Million - $1.87 Million
66,430 Added 18.27%
429,990 $8.45 Million
Q2 2023

Aug 09, 2023

BUY
$21.73 - $31.43 $102,109 - $147,689
4,699 Added 1.31%
363,560 $9.02 Million
Q1 2023

May 11, 2023

SELL
$26.15 - $37.26 $45,527 - $64,869
-1,741 Reduced 0.48%
358,861 $9.8 Million
Q4 2022

Feb 13, 2023

BUY
$32.47 - $57.24 $249,207 - $439,317
7,675 Added 2.17%
360,602 $12.3 Million
Q3 2022

Nov 14, 2022

BUY
$41.87 - $57.99 $1.32 Million - $1.83 Million
31,587 Added 9.83%
352,927 $15.7 Million
Q2 2022

Aug 15, 2022

SELL
$36.01 - $74.24 $277,601 - $572,316
-7,709 Reduced 2.34%
321,340 $13.5 Million
Q1 2022

May 13, 2022

BUY
$60.27 - $81.57 $479,930 - $649,541
7,963 Added 2.48%
329,049 $22.1 Million
Q4 2021

Feb 11, 2022

BUY
$65.85 - $96.21 $1.27 Million - $1.86 Million
19,316 Added 6.4%
321,086 $26.4 Million
Q3 2021

Nov 16, 2021

BUY
$73.2 - $107.87 $3.78 Million - $5.56 Million
51,589 Added 20.62%
301,770 $24.8 Million
Q2 2021

Aug 16, 2021

BUY
$60.45 - $84.26 $1.17 Million - $1.62 Million
19,279 Added 8.35%
250,181 $19.3 Million
Q1 2021

May 17, 2021

BUY
$58.19 - $91.37 $1.12 Million - $1.76 Million
19,268 Added 9.1%
230,902 $15.3 Million
Q4 2020

Feb 16, 2021

BUY
$20.19 - $84.93 $826,457 - $3.48 Million
40,934 Added 23.98%
211,634 $18 Million
Q3 2020

Nov 13, 2020

BUY
$22.99 - $36.34 $874,079 - $1.38 Million
38,020 Added 28.66%
170,700 $4.03 Million
Q2 2020

Aug 14, 2020

BUY
$29.88 - $56.74 $682,817 - $1.3 Million
22,852 Added 20.81%
132,680 $4.45 Million
Q1 2020

May 15, 2020

BUY
$33.0 - $54.5 $133,584 - $220,616
4,048 Added 3.83%
109,828 $4.43 Million
Q4 2019

Feb 07, 2020

BUY
$15.39 - $44.38 $432,474 - $1.25 Million
28,101 Added 36.18%
105,780 $4.35 Million
Q3 2019

Nov 08, 2019

BUY
$21.55 - $27.61 $265,366 - $339,989
12,314 Added 18.84%
77,679 $1.67 Million
Q2 2019

Aug 09, 2019

BUY
$15.96 - $23.8 $346,475 - $516,674
21,709 Added 49.73%
65,365 $1.44 Million
Q1 2019

May 14, 2019

BUY
$13.55 - $23.79 $12,100 - $21,244
893 Added 2.09%
43,656 $645,000
Q4 2018

Feb 14, 2019

BUY
$11.19 - $18.56 $478,517 - $793,681
42,763 New
42,763 $550,000

Others Institutions Holding ARVN

About ARVINAS, INC.


  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $997M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.